In the industry of clinical research, we are accustomed to working with conservative companies that make decisions slowly. Look at the adoption of EDC – over how many decades now? Understandable, at least to a point. I’ve been in my new role at Phesi for 2 weeks now, and I am witnessing a refreshing change. Artificial intelligence started to sneak…
In our last blog we talked about the importance of site level insights in making solid decisions about which investigators can successfully support your trial. In this blog we give further insights about how ClinSite can support decision making on investigator site selection in NASH, a fiercely competitive space for investigator site patient enrollment. When we launched ClinSite at DIA…
As we head into Thanksgiving, we reflect upon all we have accomplished since January and our vision for 2020. At Phesi, we had quite a few firsts in 2019 and much to be thankful for, such as: Successfully launching our flagship product, ClinSite™ – a self-service, artificial intelligence (AI)-powered tool that enables biopharmaceutical companies to search for and select top-performing…